| Pharmaceutical active ingredients: |
| ChloramphenicolSulfacetamide Sodium |
| Available forms, composition and doses of Sulfachloramphenicol: |
| N / A |
| Sulfachloramphenicol medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D06AX02 - ChloramphenicolD10AF03 - ChloramphenicolS01AB04 - Sulfacetamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sulfacetamide | Sulfacetamide Sodium | Taro Pharmaceutical Industries |
| Sulfacetamide; Prednisolone | Prednisolone Sodium Phosphate; Sulfacetamide Sodium | Alcon |
| Sulfacetamide; Prednisolone | Prednisolone Sodium Phosphate; Sulfacetamide Sodium | Bausch and Lomb |
| Sulfacetil | Anileridine | Unidentified Pharmaceutical Company |
| Sulfacet-R | Sulfacetamide Sodium; Sulfur | Sanofi-Aventis; Dermik Laboratories |
| Sulfacid | Sulfacetamide Sodium | Fischer Pharmaceuticals |
| Sulfacide | Sulfacetamide Sodium | Fischer Pharmaceuticals |
| Sulfacollyre | Sulfacetamide Sodium | Sterop |
| Sulfacombin | Sulfadiazine | Unidentified Pharmaceutical Company |
| Sulfacort | Prednisolone Acetate; Sulfacetamide Sodium | L.O. Oftalmi Laboratorios |